← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 24.6% to $146.6M, while Net income decreased 123.0% to ($9.4M).
The read at a glance✓ Audited against SEC data
- Scale — FY2025 revenue $146.6MWatch
- Profitability — Net income ($9.4M)Watch
- Cash generation — Free cash flow $149.0KOK
- Accounting — Distress-safe · manipulation flag raised · earnings quality safeWatch
- Insiders — 0 buys; 0 sells in 365 daysNote
- Capital — share repurchases were $9.7MNote
Business
Cronos Group Inc.: ("High Tide"), as borrower, and a warrant (the "High Tide Warrant") to purchase common shares of High Tide, the performance of the High Tide Loan and the High Tide Warrant, and High Tide's ability to repay the High Tide Loan; expectations related to our agreement to acquire CanAdelaar B.V.
Where the revenue comes from
Fiscal 2025, as Cronos Group Inc. reports it. History and quarterly detail are in the app.
- Cannabis flower$108.5M
- Cannabis extracts$37.7M
- Other$411K
Leadership changes
From Cronos Group Inc.'s own filings, the day they're filed.
- Lloyd Wilson · President · departureeff. 2025-08-29
- James Holm · Chief Financial Officer · departure
- Cronos Israel · Chairman · departure
Latest filings
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-06-22
- 8-K · Company announcement2026-05-11
- 10-Q · Quarterly report2026-05-11
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Cronos Group Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.